Point of Care Nano-Technology (PCNT) 10-K 20 Nov 15 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Jul. 31, 2015	Nov. 20, 2015	Jan. 30, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	Point of Care Nano-Technology, Inc.
Entity Central Index Key	1,504,239
Amendment Flag	false
Current Fiscal Year End Date	--07-31
Document Type	10-K
Document Period End Date	Jul. 31, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	Yes
Entity Current Reporting Status	No
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 8,860,550
Entity Common Stock, Shares Outstanding		46,253,803

Balance Sheets

Balance Sheets - USD ($)	Jul. 31, 2015	Jul. 31, 2014
Current Assets
Cash	$ 4,045	$ 177,181
Total Assets	4,045	177,181
Current Liabilities
Accounts Payable & Accrued Expenses	213,580	218,727
Accrued Interest Payable	11,767	4,313
Notes Payable	$ 95,034	26,034
Loan payable Notes Payable - Related Party		100,000
Total Liabilities	$ 320,381	$ 349,074
Commitments and Contingencies (See Note 5)
Stockholders' Deficiency
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, none issued and outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized,44,956,953 shares and 18,406,528 issued and outstanding, respectively	$ 4,496	$ 1,841
Additional paid-in capital	119,742,637	1,087,328
Accumulated deficit	(120,063,469)	(1,261,062)
Total Stockholders' Deficiency	(316,336)	(171,893)
Total Liabilities and Stockholders' Deficiency	$ 4,045	$ 177,181

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Jul. 31, 2015	Jul. 31, 2014
Balance Sheets [Abstract]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	44,956,953	18,406,528
Common stock, shares outstanding	44,956,953	18,406,528

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
	Jul. 31, 2015	Jul. 31, 2014
Operating Expenses
Professional fees	$ 57,575	$ 46,270
Consulting Expense	110,500	$ 54,163
Stock Based Compensation - Settlement Agreement	260,000
Stock Based Compensation - Officer	118,125,000
Salary - Officer	181,500
General and Administrative	47,384	$ 84,686
Total Operating Expenses	118,781,959	185,119
LOSS FROM OPERATIONS BEFORE INCOME TAXES	(118,781,959)	(185,119)
Other Income/Expenses
Gain on Debt Settlement		13,605
Interest Expense	$ (20,448)	$ (17,885)
Provision for Income Taxes
NET LOSS	$ (118,802,407)	$ (189,399)
Net Loss Per Share - Basic and Diluted	$ (4)	$ (0.01)
Weighted average number of shares outstanding during the period - Basic and Diluted	29,686,555	18,406,519

Statement of Changes in Stockho

Statement of Changes in Stockholders' Equity (Deficiency) - USD ($)	Total	Preferred Stock	Common stock	Additional paid-in capital	Accumulated Deficit
Beginning Balance at Jul. 31, 2013	$ (271,707)		$ 1,808	$ 798,148	$ (1,071,663)
Beginning Balance, Shares at Jul. 31, 2013			18,077,550
In kind contribution of services	15,600			15,600
Proceeds from exercise of warrants	273,056		$ 33	273,023
Proceeds from exercise of warrants, Shares			328,978
In kind contribution of interest	557			$ 557
Net loss for the year ended July 31, 2015	(189,399)				$ (189,399)
Ending Balance at Jul. 31, 2014	(171,893)		$ 1,841	$ 1,087,328	$ (1,261,062)
Ending Balance, Shares at Jul. 31, 2014			18,406,528
In kind contribution of services	10,400			10,400
Payment of expenses on Company's behalf	2,612			2,612
Stock based compensation - settlement	260,000		$ 10	259,990
Stock based compensation - settlement, Shares			100,000
Stock based compensation - officer	118,125,000		$ 3,750	118,121,250
Stock based compensation - officer, Shares			37,500,000
Cancellation of shares	(115,000)		$ (1,150)	(113,850)
Cancellation of shares, Shares			(11,500,000)
Proceeds from exercise of warrants	373,852		$ 45	$ 373,807
Proceeds from exercise of warrants, Shares			450,425
In kind contribution of interest	1,100			$ 1,100
Net loss for the year ended July 31, 2015	(118,802,407)				$ (118,670,714)
Ending Balance at Jul. 31, 2015	$ (316,336)		$ 4,496	$ 119,742,637	$ (120,063,469)
Ending Balance, Shares at Jul. 31, 2015			44,956,953

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Jul. 31, 2015	Jul. 31, 2014
Cash Flows Used in Operating Activities:
Net Loss	$ (118,802,407)	$ (189,399)
Adjustments to reconcile net loss to net cash used in operations
Bad debt expense		$ 25,000
Stock based compensation - settlement agreement	$ 260,000
Stock based compensation - officer	118,125,000
In-kind contribution of services	10,400	$ 15,600
In-kind contribution of interest	1,100	$ 557
Payments of expenses on the Company's behalf	2,612
Changes in operating assets and liabilities:
Increase(Decrease) in accounts payable and accrued expenses	2,307	$ (13,041)
Net Cash Used In Operating Activities	$ (400,988)	(161,283)
Cash Flows From Investing Activities:
Increase in note receivable		(25,000)
Net Cash Used in Investing Activities		$ (25,000)
Cash Flows From Financing Activities:
Proceeds from note payable	$ 114,444
Repayment of loan payable	$ (45,444)
Proceeds from loan payable- Related party		$ 101,500
Repayment of loan payable - Related party	$ (100,000)	$ (11,217)
Common shares repurchased for cancellation	(115,000)
Proceeds from exercise of warrants	373,852	$ 273,056
Net Cash Provided by Financing Activities	227,852	363,339
Net Increase (Decrease) in Cash	(173,136)	177,056
Cash at Beginning of Period	177,181	125
Cash at End of Period	$ 4,045	177,181
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest		$ 5,333
Cash paid for taxes

Summary of Significant Accounti

Summary of Significant Accounting Policies and Organization	12 Months Ended
	Jul. 31, 2015
Summary of Significant Accounting Policies and Organization [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION	NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (A) Organization Alternative Energy and Environmental Solutions, Inc. (the "Company") was incorporated under the laws of the State of Nevada on June 10, 2010 to market an innovative new biotechnology that utilizes nutrient stimulants - organic microbes - to extract coalbed methane more efficiently in high-production as well as from low-producing, depleted and abandoned coalmines in the U.S. Coalbed methane is a clean-burning natural gas used for heating in homes and is used to generate electricity. On August 28, 2014, the Company filed an amendment to its Articles of Incorporation changing the name of the Company to “Unique Growing Solutions, Inc.” On March 31, 2015, the Company filed an amendment to its Articles of Incorporation changing the name of the Company to “Point of Care Nano-Technology, Inc.” (B) Use of Estimates In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include valuation of equity based on transactions and the valuation of deferred tax assets. (C) Cash and Cash Equivalents The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. At July 31, 2015 and July 31, 2014, the Company had no cash equivalents. (D) Loss Per Share In accordance with the accounting guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260, Earnings per Share, Since the Company reflected a net loss for the year ended July 31, 2015 and 2014, the effect of 80,005 and 5,826,122 warrants, respectively, is anti-dilutive. A separate computation of diluted loss per share is not presented. (E) Income Taxes The Company accounts for income taxes under FASB ASC Topic 740, Income Taxes (“ASC Topic 740”). Under ASC Topic 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC Topic 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. July 31, 2014 July 31, 2013 Deferred tax liability $ - $ - Deferred tax asset Net Operating Loss Carryforward 617,408 460,931 Valuation Allowance (617,408 ) (460,931 ) Net deferred tax asset - - Net deferred tax liability - $ - $ - The net deferred tax liability in the accompanying balance sheets includes the following amounts of deferred tax assets and liabilities: The valuation allowance was established to reduce the deferred tax asset to the amount that will more likely than not be realized. This is necessary due to the Company’s continued operating losses and the uncertainty of the Company’s ability to utilize all of the net operating loss carryforwards before they will expire through the year 2035. The net deferred tax liability in the accompanying balance sheets includes the following amounts of deferred tax assets and liabilities: As of July 31, 2015, the Company has a net operating loss carryforward of approximately $1,601,555 available to offset future taxable income through July 31, 2035. The valuation allowance was established to reduce the deferred tax asset to the amount that will more likely than not be realized. This is necessary due to the Company’s continued operating losses and the uncertainty of the Company’s ability to utilize all of the net operating loss carryforwards before they will expire through the year 2035. The Company’s federal income tax returns for the years ended July 31, 2010 through July 31, 2015 remain subject to examination by the Internal Revenue Service and State Taxing Authorities as of July 31, 2015. The net change in the valuation allowance for the year ended July 31, 2015 and 2014 was an increase of $156,477 and $66,784, respectively. The net deferred tax liability in the accompanying balance sheets includes the following amounts of deferred tax assets and liabilities: July 31, 2015 July 31, 2014 Federal Current - - Deferred - - - - State and Local Current - - Deferred - - - - The Company's income tax expense differed from the statutory rates (federal 34% and state 4.55%) as follows: July 31, July 31, 2014 Statutory rate applied to earnings before income taxes: $ (45,798,328 ) $ (73,013 ) Increase (decrease) in income taxes resulting from: State income taxes - - Change in deferred tax asset valuation allowance 156,477 66,784 Non-deductible expenses 45,641,851 6,229 Income Tax Expense $ - $ - (F) Business Segments The Company operates in one segment and therefore segment information is not presented. (G) Revenue Recognition The Company will recognize revenue on arrangements in accordance with FASB ASC Topic 605, Revenue Recognition (H) Fair Value of Financial Instruments The carrying amounts on the Company’s financial instruments including accounts payable and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. (I) Stock Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. (J) Recent Accounting Pronouncements In April 2015, FASB issued Accounting Standards Update (“ASU”) No. 2015-03, “ Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs”, is to simplify presentation of debt issuance costs by requiring that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The ASU does not affect the recognition and measurement guidance for debt issuance costs. For public companies, the ASU is effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early application is permitted. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition. In April 2015, FASB issued Accounting Standards Update (“ASU”) No. 2015-04, “Compensation – Retirement Benefits (Topic 715): Practical Expedient for the Measurement Date of an Employer’s Defined Benefit Obligation and Plan Assets”, permits the entity to measure defined benefit plan assets and obligations using the month-end that is closest to the entity’s fiscal year-end and apply that practical expedient consistently from year to year. The ASU is effective for public business entities for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early application is permitted. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition. In April 2015, FASB issued Accounting Standards Update (“ASU”) No. 2015-05, “Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement”, provides guidance to customers about whether a cloud computing arrangement includes a software license. If such an arrangement includes a software license, then the customer should account for the software license element of the arrangement consistent with the acquisition of other software licenses. If the arrangement does not include a software license, the customer should account for it as a service contract. For public business entities, the ASU is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2015. Early application is permitted. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition. In April 2015, FASB issued Accounting Standards Update (“ASU”) No. 2015-06, “Earnings Per Share (Topic 260): Effects on Historical Earnings per Unit of Master Limited Partnership Dropdown Transactions”, specifies that, for purposes of calculating historical earnings per unit under the two-class method, the earnings (losses) of a transferred business before the date of a drop down transaction should be allocated entirely to the general partner. In that circumstance, the previously reported earnings per unit of the limited partners (which is typically the earnings per unit measure presented in the financial statements) would not change as a result of the dropdown transaction. Qualitative disclosures about how the rights to the earnings (losses) differ before and after the dropdown transaction occurs for purposes of computing earnings per unit under the two-class method also are required. The ASU is effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Earlier application is permitted. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition. All other newly issued accounting pronouncements, but not yet effective, have been deemed either immaterial or not applicable.

Notes Payable

Notes Payable	12 Months Ended
	Jul. 31, 2015
Notes Payable [Abstract]
NOTES PAYABLE	NOTE 2 NOTES PAYABLE On October 10, 2014, the Company issued an unsecured promissory note to a unrelated party in the amount of $100,000 which is due on or before the 90 th On August 29, 2014 the Company entered into a promissory note with an unrelated party. This is a non-interest bearing loan for $14,444 and is due on demand. On July 22, 2015 the company repaid $1,444 and on July 23, 2015, the Company repaid $2,000. The remaining loan balance due is $11,000 as of July 31, 2015. For the year ended July 31, 2015 the Company recorded $795, as an in-kind contribution of interest (see note 4(A)). On November 13, 2012, the Company received $6,034 from an unrelated party. Pursuant to the terms of the note, the note is non-interest bearing, unsecured and is due on demand. For the years ended July 31, 2015 and 2014 the Company recorded $304 and $387 respectively, as an in-kind contribution of interest (see Note 4(A)). On August 23, 2011, the Company issued an unsecured promissory note in the amount of $10,000 which was due on August 23, 2012 and bearing compounding interest at a rate of 6% per annum. Interest on the outstanding principal balance is payable quarterly in arrears on the last day of each calendar quarter. The Company is currently in default of this note and expects to make the necessary payments whenever the Company is able to make such payments. Then on December 28, 2011, the Company issued an additional unsecured promissory note in the amount of $10,000 which was due on December 28, 2012 and bearing compounding interest at a rate of 6% per annum. Interest on the outstanding principal balance is payable quarterly in arrears on the last day of each calendar quarter. The Company is currently in default of these notes and expects to make the necessary payments whenever the Company is able to make such payments. As of July 31, 2015 and July 31, 2014, the Company recorded $5,033 and $3,585, in accrued interest, respectively.

Notes Payable - Related Party

Notes Payable - Related Party	12 Months Ended
	Jul. 31, 2015
Notes Payable - Related Party [Abstract]
NOTES PAYABLE - RELATED PARTY	NOTE 3 NOTES PAYABLE - RELATED PARTY On November 4, 2013, the Company issued an unsecured promissory note to a related party in the amount of $100,000 which is due on February 3, 2014. The note bears interest at a rate of 8% per annum. On August 1, 2014 the Company repaid the $100,000 note and $5,333 of accrued interest. As of July 31, 2015 and July 31, 2014, the Company recorded $0 and $6,060, respectively, in accrued interest (see Note 6). During the year ended July 31, 2013, a related party paid $2,023 in expenses on Company’s behalf in exchange for a note payable. Pursuant to the terms of the note, the note was non-interest bearing, unsecured and was due on demand. During the year ended July 31, 2014, the same related party paid $1,500 in expenses on the Company’s behalf in exchange for a note payable. Pursuant to the terms of the note, the note is non-interest bearing, unsecured and is due on demand. For the year ended July 31, 2014 the Company recorded $42 as an in-kind contribution of interest. The note was repaid in full during the year ended July 31, 2014 (see Notes 4(A) & 6). On June 10, 2013, the Company received $7,694 from a related party. Pursuant to the terms of the note, the note was non-interest bearing, unsecured and was due on demand. For the year ended July 31, 2014, the Company recorded $129 as an in-kind contribution of interest. The note was repaid in full during the year ended July 31, 2014 (see Notes 4(A) & 6).

Stockholders' Deficiency

Stockholders' Deficiency	12 Months Ended
	Jul. 31, 2015
Stockholders' Deficiency [Abstract]
STOCKHOLDERS' DEFICIENCY	NOTE 4 STOCKHOLDERS’ DEFICIENCY (A) In-Kind Contribution For the year ended July 31, 2015, a shareholder of the Company contributed services having a fair value of $10,400 (See Note 6). For the year ended July 31, 2014, a shareholder of the Company contributed services having a fair value of $15,600 (See Note 6). For the year ended July 31, 2015, the Company recorded a total of $1,100 as an in-kind contribution of interest (See Notes 2 & 6). For the year ended July 31, 2014, the Company recorded a total of $557 as an in-kind contribution of interest (See Notes 2, 3 & 6). (B) Warrants The following tables summarize all warrant grants for the year ended July 31, 2015, and the related changes during these periods are presented below. Number of Warrants Weighted Average Exercise Warrants Balance at July 31, 2014 5,826,122 $ 0.83 Granted - - Exercised (450,425 ) - Forfeited (5,295,692 ) - Balance at July 31, 2015 80,005 0.83 Warrants exercisable at July 31, 2015 80,005 $ 0.83 Of the total warrants outstanding, 80,005 are fully vested, exercisable and non-forfeitable. These warrants are immediately exercisable at $0.83 per share and are immediately callable by the Company if the Company’s common stock trades for a period of 20 consecutive days at an average trading price of $1.00 per share or greater. This option gives the Company the right, but not the obligation to repurchase the shares of common stock. During the year ended July 31, 2015 and year ended July 31, 2014, the average trading price exceeded $1.00 per share and the options are callable by the Company, although none have been called to date. During the year ended July 31, 2015, the Company issued 450,425 shares of common stock, in connection with the exercise of stock warrants, for proceeds of approximately $373,852. During the year ended July 31, 2014, the Company issued 328,978 shares of common stock, in connection with the exercise of stock warrants, for proceeds of approximately $273,056. (C) Payments made on the Company’s behalf For the year ended July 31, 2015, a related party paid legal expenses on behalf of the Company totaling $2,612, which was forgiven and recorded as an in-kind contribution of capital. (D) Common stock issued in connection with release and settlement agreement For the year ended July 31, 2015, the Company issued 100,000 shares valued at $260,000 ($2.60/share), in connection with release and settlement agreement entered on October 7, 2014 (See Note 5). (E) Common stock cancellations On February 25, 2014, the Company entered into two separate Cancellation Agreements, one with the former sole officer and sole director, and one with an affiliate of the Company under which a total of 11,500,000 shares of the Company’s common stock, par value $0.0001 per share, were cancelled and in return the two persons received an aggregate of $115,000. (F) Common stock issued in connection with employment agreement On February 26, 2015, the Company entered into an employment agreement with its new CEO. For the year ended July 31, 2015, the Company issued 37,500,000 shares valued at a fair value of $118,125,000 ($3.15/share). Fair value is based on the closing price of the stock on the date of grant.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Jul. 31, 2015
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 5 COMMITMENTS AND CONTINGENCIES On June 4, 2010, the Company entered into a consulting agreement with a related party to receive administrative and other miscellaneous services. The Company is required to pay $4,500 a month. The agreement is to remain in effect unless either party desires to cancel the agreement. On August 1, 2014, the Company entered into an Employment Agreement with a member of the board of directors to serve as the Chief Executive Officer, President, and Chief Financial Officer of the Company. Pursuant to the Agreement and in consideration for his services as the sole officer of the Company, the Company immediately issued 25 million shares of the Company’s common stock to the new CEO. At the time, the CEO had control of over 50% of the Company’s common stock, giving the CEO control of the Company. In addition, pursuant to the Agreement, the CEO was to be paid $240,000 in base salary per year and, once a Certificate of Designation of “Series A Preferred Stock” was filed with the Secretary of State of the State of Nevada, the CEO was to be issued shares of the Company’s Series A Series Preferred Stock. Subsequently, on October 7, 2014, the Company entered into a settlement and release agreement with the CEO. In connection with the release and settlement agreement, the CEO submitted his resignation and the future issuance of shares of preferred stock was cancelled. In addition, the Company agreed to the following additional terms in connection with the release: ● Payment of $40,000 to the old CEO which represented two months of salary. This was paid during October 2014. ● Payment of a one-time consulting fee of $12,000 to the old CEO. This was paid during October 2014. ● The old CEO has returned the physical share certificates evidencing his ownership of 25 million shares of the Company’s common stock and the Company instructed its transfer agent to cancel these 25 million shares. This occurred on December 11, 2014. ● The Company is required to: (i) issue 100,000 shares of the Company’s common stock to the old CEO; and (ii) change its name from Unique Growing Solutions to another name. For the year ended July 31, 2015, the Company issued 100,000 shares valued at $260,000 ($2.60/share) (See Note 4(D)), and changed the Company’s name to Point of Care Nano-Technology, Inc. ● In the event that an additional agreed upon event occurs, the Company shall issue an additional 100,000 shares of the Company’s common stock to the old CEO. During the year ended July 31, 2015, no additional agreed upon events have occurred. On February 25, 2015, the Company signed an Employment Agreement with Dr. Guirguis (the “Employment Agreement”). Pursuant to the Employment Agreement, the Company appointed Dr. Guirguis as Chief Executive Officer of the Company effective as of February 26, 2015 (the “Employment Effective Date”). The Company will pay Dr. Guirguis an annual salary of $350,000. In addition, within twenty days of the Employment Effective Date, the Company will issue 37,500,000 shares of the Company’s common stock to Dr. Guirguis (the “Stock Issuance”). The Stock Issuance will result in a change of control of the Company. For the year ended July 31, 2015, the Company issued 37,500,000 shares with a fair value of $118,125,000 ($3.15/share), (See Note 4(F)), Fair value is based on the closing price of the stock on the date of grant. In addition, during the year ended July 31, 2015, the Company paid expenses previously incurred by CEO in the amount of $45,000 and was recorded as an additional compensation expense and approved by the Company’s Board of Directors. For the year ended July 31, 2015 the compensation expense is $181,500. On February 25, 2015, the Company entered into a License Agreement with Lamina Equities Corporation (“Lamina”). Lamina is a private corporation over which Dr. Raouf Guirguis has sole control. Pursuant to the License Agreement, the Company agreed to pay $1,000 to Lamina in exchange for an exclusive worldwide license to Lamina’s intellectual property relating to diagnosing illness in humans via a saliva test. In addition, the Company will pay total regulatory milestone payments of up to $10,000 and a royalty of 7.5% of Net Sales to Lamina. During the year ended July 31, 2015, the Company paid and expensed $1,000 for the licensing rights. No other milestones have been met.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Jul. 31, 2015
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 6 RELATED PARTY TRANSACTIONS On November 19, 2014, the Company recorded $7,500 as a bonus to the former CEO, for his extra time involved with negotiating and concluding the settlement and release agreement with the CEO with the employment agreement dated August 1, 2014 and the release date of October 7, 2014. On November 4, 2013, the Company issued an unsecured promissory note to a related party in the amount of $100,000 due February 3, 2014 and bearing interest at a rate of 8% per annum. The Company is currently in default of this note and expects to make the necessary payments whenever the Company is able to make such payments. On August 1, 2014 the Company repaid $100,000 of the loan balance and $5,333 of accrued interest. As of July 31, 2015 and July 31, 2014, the Company recorded $0 and $6,060, respectively, in accrued interest (See Note 3). For the year ended July 31, 2015, a related party paid legal expenses on behalf of the Company totaling $2,612, which was forgiven and recorded as an in-kind contribution of capital (See Note 4 (C)). During the year ended July 31, 2013, a related party paid $2,023 in expenses on Company’s behalf in exchange for a note payable. Pursuant to the terms of the note, the note is non-interest bearing, unsecured and is due on demand. During the year ended July 31, 2014, the same related party paid $1,500 in expenses on the Company’s behalf in exchange for a note payable. Pursuant to the terms of the note, the note is non-interest bearing, unsecured and is due on demand. For the year ended July 31, 2014 the Company recorded $42 as an in-kind contribution of interest. The note was repaid in full during the year ended July 31, 2014 (See Notes 3 & 4(B)). During the year ended July 31, 2013 the Company received $7,694 from a related party. Pursuant to the terms of the note, the note is non-interest bearing, unsecured and is due on demand. The note was repaid in full during the year ended July 31, 2014 (See Notes 3 & 4(B)). For the year ended July 31, 2015, the Company recorded a total of $1,100 as an in-kind contribution of interest (See Notes 2 & 4). For the year ended July 31, 2014 the Company recorded a total of $557 as an in-kind contribution of interest (See Notes 2, 3 & 4(B)). For the year ended July 31, 2015, a shareholder of the Company contributed services having a fair value of $10,400 (See Note 4 (A)). For the year ended July 31, 2014, a shareholder of the Company contributed services having a fair value of $15,600 (See Note 4(A)).

Note Receivable

Note Receivable	12 Months Ended
	Jul. 31, 2015
Note Receivable [Abstract]
NOTE RECEIVABLE	NOTE 7 NOTE RECEIVABLE On November 13, 2013 the Company advanced $25,000 to an unrelated party. Pursuant to the terms of the note, the note is non-interest bearing, unsecured and is due on demand. The Company recorded an allowance for doubtful accounts of $25,000 as of July 31, 2015 and July 31, 2014 for this note.

Going Concern

Going Concern	12 Months Ended
	Jul. 31, 2015
Going Concern [Abstract]
GOING CONCERN	NOTE 8 GOING CONCERN As reflected in the accompanying financial statements, the Company has minimal operations, a working capital and stockholders’ deficiency of $316,336, used cash in operations of $400,988 and has a net loss of $118,802,407 for the year ended July 31, 2015. This raises substantial doubt about its ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Management believes that actions presently being taken to obtain additional funding and implement its strategic plans provide the opportunity for the Company to continue as a going concern.

Subsequent Events

Subsequent Events	12 Months Ended
	Jul. 31, 2015
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 9 SUBSEQUENT EVENTS Subsequent to the July 31, 2015 year end the Company issued 1,296,850 shares of common stock: (a) 675,638 shares were issued to shareholders who, subsequent to Dr. Guirguis taking control of the Company, bought shares at $0.83 per share. The 675,638 shares were issued as bonus shares so that the collective cost of all of the shares held by such shareholders is $0.33 per share. (b) 621,212 shares of common stock were issued for $205,000 ($0.33/share).

Summary of Significant Accoun16

Summary of Significant Accounting Policies and Organization (Policies)	12 Months Ended
	Jul. 31, 2015
Summary of Significant Accounting Policies and Organization [Abstract]
Organization	(A) Organization Alternative Energy and Environmental Solutions, Inc. (the "Company") was incorporated under the laws of the State of Nevada on June 10, 2010 to market an innovative new biotechnology that utilizes nutrient stimulants - organic microbes - to extract coalbed methane more efficiently in high-production as well as from low-producing, depleted and abandoned coalmines in the U.S. Coalbed methane is a clean-burning natural gas used for heating in homes and is used to generate electricity. On August 28, 2014, the Company filed an amendment to its Articles of Incorporation changing the name of the Company to “Unique Growing Solutions, Inc.” On March 31, 2015, the Company filed an amendment to its Articles of Incorporation changing the name of the Company to “Point of Care Nano-Technology, Inc.”
Use of Estimates	(B) Use of Estimates In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include valuation of equity based on transactions and the valuation of deferred tax assets.
Cash and Cash Equivalents	(C) Cash and Cash Equivalents The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. At July 31, 2015 and July 31, 2014, the Company had no cash equivalents.
Loss Per Share	(D) Loss Per Share In accordance with the accounting guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260, Earnings per Share, Since the Company reflected a net loss for the year ended July 31, 2015 and 2014, the effect of 80,005 and 5,826,122 warrants, respectively, is anti-dilutive. A separate computation of diluted loss per share is not presented.
Income Taxes	(E) Income Taxes The Company accounts for income taxes under FASB ASC Topic 740, Income Taxes (“ASC Topic 740”). Under ASC Topic 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC Topic 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. July 31, 2014 July 31, 2013 Deferred tax liability $ - $ - Deferred tax asset Net Operating Loss Carryforward 617,408 460,931 Valuation Allowance (617,408 ) (460,931 ) Net deferred tax asset - - Net deferred tax liability - $ - $ - The net deferred tax liability in the accompanying balance sheets includes the following amounts of deferred tax assets and liabilities: The valuation allowance was established to reduce the deferred tax asset to the amount that will more likely than not be realized. This is necessary due to the Company’s continued operating losses and the uncertainty of the Company’s ability to utilize all of the net operating loss carryforwards before they will expire through the year 2035. The net deferred tax liability in the accompanying balance sheets includes the following amounts of deferred tax assets and liabilities: As of July 31, 2015, the Company has a net operating loss carryforward of approximately $1,601,555 available to offset future taxable income through July 31, 2035. The valuation allowance was established to reduce the deferred tax asset to the amount that will more likely than not be realized. This is necessary due to the Company’s continued operating losses and the uncertainty of the Company’s ability to utilize all of the net operating loss carryforwards before they will expire through the year 2035. The Company’s federal income tax returns for the years ended July 31, 2010 through July 31, 2015 remain subject to examination by the Internal Revenue Service and State Taxing Authorities as of July 31, 2015. The net change in the valuation allowance for the year ended July 31, 2015 and 2014 was an increase of $156,477 and $66,784, respectively. The net deferred tax liability in the accompanying balance sheets includes the following amounts of deferred tax assets and liabilities: July 31, 2015 July 31, 2014 Federal Current - - Deferred - - - - State and Local Current - - Deferred - - - - The Company's income tax expense differed from the statutory rates (federal 34% and state 4.55%) as follows: July 31, July 31, 2014 Statutory rate applied to earnings before income taxes: $ (45,798,328 ) $ (73,013 ) Increase (decrease) in income taxes resulting from: State income taxes - - Change in deferred tax asset valuation allowance 156,477 66,784 Non-deductible expenses 45,641,851 6,229 Income Tax Expense $ - $ -
Business Segments	(F) Business Segments The Company operates in one segment and therefore segment information is not presented.
Revenue Recognition	(G) Revenue Recognition The Company will recognize revenue on arrangements in accordance with FASB ASC Topic 605, Revenue Recognition
Fair Value of Financial Instruments	(H) Fair Value of Financial Instruments The carrying amounts on the Company’s financial instruments including accounts payable and notes payable, approximate fair value due to the relatively short period to maturity for these instruments.
Stock Based Compensation	(I) Stock Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period.
Recent Accounting Pronouncements	(J) Recent Accounting Pronouncements In April 2015, FASB issued Accounting Standards Update (“ASU”) No. 2015-03, “ Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs”, is to simplify presentation of debt issuance costs by requiring that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The ASU does not affect the recognition and measurement guidance for debt issuance costs. For public companies, the ASU is effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early application is permitted. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition. In April 2015, FASB issued Accounting Standards Update (“ASU”) No. 2015-04, “Compensation – Retirement Benefits (Topic 715): Practical Expedient for the Measurement Date of an Employer’s Defined Benefit Obligation and Plan Assets”, permits the entity to measure defined benefit plan assets and obligations using the month-end that is closest to the entity’s fiscal year-end and apply that practical expedient consistently from year to year. The ASU is effective for public business entities for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early application is permitted. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition. In April 2015, FASB issued Accounting Standards Update (“ASU”) No. 2015-05, “Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement”, provides guidance to customers about whether a cloud computing arrangement includes a software license. If such an arrangement includes a software license, then the customer should account for the software license element of the arrangement consistent with the acquisition of other software licenses. If the arrangement does not include a software license, the customer should account for it as a service contract. For public business entities, the ASU is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2015. Early application is permitted. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition.

Summary of Significant Accoun17

Summary of Significant Accounting Policies and Organization (Tables)	12 Months Ended
	Jul. 31, 2015
Summary of Significant Accounting Policies and Organization [Abstract]
Net deferred tax liability in accompanying balance sheets includes amounts of deferred tax assets and liabilities	July 31, 2014 July 31, 2013 Deferred tax liability $ - $ - Deferred tax asset Net Operating Loss Carryforward 617,408 460,931 Valuation Allowance (617,408 ) (460,931 ) Net deferred tax asset - - Net deferred tax liability - $ - $ -
Summary of income tax expense related to continuing operations	July 31, 2015 July 31, 2014 Federal Current - - Deferred - - - - State and Local Current - - Deferred - - - -
Summary of company's income tax expense differed from the statutory rates	July 31, July 31, 2014 Statutory rate applied to earnings before income taxes: $ (45,798,328 ) $ (73,013 ) Increase (decrease) in income taxes resulting from: State income taxes - - Change in deferred tax asset valuation allowance 156,477 66,784 Non-deductible expenses 45,641,851 6,229 Income Tax Expense $ - $ -

Stockholders' Deficiency (Table

Stockholders' Deficiency (Tables)	12 Months Ended
	Jul. 31, 2015
Stockholders' Deficiency [Abstract]
Summary of warrant grants	Number of Warrants Weighted Average Exercise Warrants Balance at July 31, 2014 5,826,122 $ 0.83 Granted - - Exercised (450,425 ) - Forfeited (5,295,692 ) - Balance at July 31, 2015 80,005 0.83 Warrants exercisable at July 31, 2015 80,005 $ 0.83

Summary of Significant Accoun19

Summary of Significant Accounting Policies and Organization (Details ) - USD ($)	Jul. 31, 2014	Jul. 31, 2013
Net deferred tax liability in accompanying balance sheets includes amounts of deferred tax assets and liabilities
Deferred tax liability
Deferred tax asset
Net Operating Loss Carryforward	$ 617,408	$ 460,931
Valuation Allowance	$ (617,408)	$ (460,931)
Net deferred tax asset
Net deferred tax liability
Net deferred tax assets and liabilities

Summary of Significant Accoun20

Summary of Significant Accounting Policies and Organization (Details 1) - USD ($)	12 Months Ended
	Jul. 31, 2015	Jul. 31, 2014
Federal
Current
Deferred
Total
State and Local
Current
Deferred
Total

Summary of Significant Accoun21

Summary of Significant Accounting Policies and Organization (Details 2) - USD ($)	12 Months Ended
	Jul. 31, 2015	Jul. 31, 2014
Summary of company's income tax expense differed from the statutory rates
Statutory rate applied to earnings before income taxes:	$ (45,798,328)	$ (73,013)
Increase (decrease) in income taxes resulting from:
State income taxes
Change in deferred tax asset valuation allowance	$ 156,477	$ 66,784
Non-deductible expenses	$ 45,641,851	$ 6,229
Income Tax Expense

Summary of Significant Accoun22

Summary of Significant Accounting Policies and Organization (Details Textual)	12 Months Ended
	Jul. 31, 2015USD ($)Segmentshares	Jul. 31, 2014USD ($)shares
Summary of Significant Accounting Policies and Organization (Textual)
Cash equivalents	$ 0	$ 0
Net operating loss carryforward	$ 1,601,555
Operating loss carryforward expiration date	Jul. 31, 2035
Net change in the valuation allowance	$ 156,477	$ 66,784
Federal statutory rate	34.00%
State statutory rate	4.55%
Number of segment | Segment	1
Warrant [Member]
Summary of Significant Accounting Policies and Organization (Textual)
Anti-dilutive securities excluded from computation of earnings per share | shares	80,005	5,826,122

Notes Payable (Details)

Notes Payable (Details) - USD ($)

Mar. 02, 2015

Aug. 29, 2014

Nov. 13, 2012

Jul. 24, 2015

Jul. 24, 2015

Jul. 23, 2015

Jul. 22, 2015

Dec. 28, 2011

Aug. 23, 2011

Jul. 31, 2015

Jul. 31, 2014

Oct. 10, 2014

Notes Payable (Textual)

Proceeds from note payable

$ 114,444

In kind contribution of interest

1,100

$ 557

Unrelated party [Member]

Notes Payable (Textual)

Proceeds from note payable

$ 6,034

In kind contribution of interest

304

387

Promissory note [Member]

Notes Payable (Textual)

Principal amount of unsecured promissory note

$ 10,000

$ 10,000

Interest rate on unsecured promissory note, per annum

6.00%

6.00%

Unsecured promissory note due date

Dec. 28, 2012

Aug. 23, 2012

Accrued Interest

5,033

$ 3,585

Promissory note one [Member] | Unrelated party [Member]

Notes Payable (Textual)

Principal amount of unsecured promissory note

$ 100,000

Repaid loan amount

$ 35,000

$ 5,000

$ 2,000

Balance amount due to related party

58,000

Interest rate on unsecured promissory note, per annum

9.00%

Accrued Interest

5,979

Promissory note two [Member] | Unrelated party [Member]

Notes Payable (Textual)

Repaid loan amount

$ 11,000

$ 2,000

$ 1,444

Proceeds from note payable

$ 14,444

In kind contribution of interest

$ 795

Notes Payable - Related Party (

Notes Payable - Related Party (Details) - USD ($)	Aug. 01, 2014	Nov. 04, 2013	Jun. 10, 2013	Jul. 31, 2015	Jul. 31, 2014	Jul. 31, 2013
Notes Payable Related Party (Textual)
In kind contribution of interest				$ 1,100	$ 557
Repayment of note payable to related party				$ 100,000	11,217
Proceeds from related party note					101,500
Related party [Member]
Notes Payable Related Party (Textual)
In kind contribution of interest				$ 1,100	129
Proceeds from related party note			$ 7,694			$ 7,694
Related party [Member] | Notes Payable [Member]
Notes Payable Related Party (Textual)
Principal amount of unsecured promissory note		$ 100,000
Interest rate on unsecured promissory note, per annum		8.00%
Unsecured promissory note due date		Feb. 3, 2014
Accrued Interest	$ 5,333			$ 0	6,060
In kind contribution of interest					42
Repayment of note payable to related party	$ 100,000
Related party expenses					$ 1,500	$ 2,023

Stockholders' Deficiency (Detai

Stockholders' Deficiency (Details) - Warrant [Member]	12 Months Ended
	Jul. 31, 2015$ / sharesshares
Summary of warrants granted and related changes during period
Number of Warrant, Beginning Balance | shares	5,826,122
Number of Warrants Granted | shares
Number of Warrant, Exercised | shares	(450,425)
Number of Warrants Forfeited | shares	(5,295,692)
Number of Warrant, Ending Balance | shares	80,005
Number of Warrants, Exercisable | shares	80,005
Weighted Average Exercise Price, Beginning Balance	$ 0.83
Weighted Average Exercise Price, Granted
Weighted Average Exercise Forfeited
Weighted Average Exercise Price, Ending Balance
Weighted Average Exercise Price, Exercised	$ 0.83
Weighted Average Exercise Price, Exercisable	$ 0.83

Stockholders' Deficiency (Det26

Stockholders' Deficiency (Details Textual) - USD ($)	1 Months Ended	12 Months Ended
	Feb. 25, 2015	Jul. 31, 2015	Jul. 31, 2014
Stockholders' Equity (Textual)
In kind contribution of interest		$ 1,100	$ 557
Exercise price of warrants		$ 0.83
Common stock shares issued		100,000	328,978
Proceeds from issuance of common stock		$ 260,000	$ 273,056
Share price		$ 2.60
In kind contribution of services		$ 10,400	$ 15,600
Rights to call the warrants, description		Company's common stock trades for a period of 20 consecutive days at an average trading price of $1.00 per share or greater.
Average trading price exceeded		$ 1	$ 1
Legal expenses		$ 2,612
Chief Executive Officer [Member]
Stockholders' Equity (Textual)
Common stock shares issued		37,500,000
Proceeds from issuance of common stock		$ 118,125,000
Share price		$ 3.15
Cancellation Agreement [Member]
Stockholders' Equity (Textual)
Total number of common stock shares cancelled	11,500,000
Common stock, price per share	$ 0.0001
Common stock cancellation retuned amount	$ 115,000
Warrant [Member]
Stockholders' Equity (Textual)
Total number of warrants outstanding		80,005
Common stock shares issued		450,425
Proceeds from issuance of common stock		$ 373,852

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Dec. 11, 2014	Oct. 07, 2014	Aug. 01, 2014	Jun. 04, 2010	Apr. 30, 2015	Feb. 25, 2015	Jul. 31, 2015	Jul. 31, 2014
Commitments and Contingencies (Textual)
Administrative and other miscellaneous services				$ 4,500
Common stock shares issued							100,000	328,978
Common stock shares issued, Value							$ 260,000	$ 273,056
Share price							$ 2.60
Consulting fee							$ 110,500	$ 54,163
Compensation expense							$ 260,000
Pay to Lamina in exchange for worldwide license					$ 1,000	$ 1,000
Total regulatory milestone payments						10,000
Dr. Guirguis [Member]
Commitments and Contingencies (Textual)
Common stock shares issued							37,500,000
Common stock shares issued, Value							$ 118,125,000
Share price							$ 3.15
Shares issued for services			25,000,000
Percentage of ownership			50.00%
Annual salary			$ 240,000			$ 350,000
Additional shares of common stock issued						37,500,000
Compensation expense							$ 181,500
Prepaid expense incurred							$ 45,000
Former CEO [Member]
Commitments and Contingencies (Textual)
Common stock shares issued							100,000
Annual salary		$ 40,000
Consulting fee		$ 12,000
Returning common stock certificates	25,000,000
Common stock cancelled	25,000,000
Additional shares of common stock issued							100,000
Royalty Agreements [Member]
Commitments and Contingencies (Textual)
Concentration risk percentage						7.50%

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Nov. 19, 2014	Aug. 01, 2014	Nov. 04, 2013	Jun. 10, 2013	Jul. 31, 2015	Jul. 31, 2014	Jul. 31, 2013
Related Party Transactions (Textual)
Bonus to former CEO					$ 181,500
Repayment of loan balance to related party					100,000	$ 11,217
In kind contribution of interest					$ 1,100	557
Proceeds from related party note						101,500
In kind contribution of services					$ 10,400	$ 15,600
Payments of expenses on the Company's behalf					$ 2,612
Former Cheif Executive Officer [Member]
Related Party Transactions (Textual)
Bonus to former CEO	$ 7,500
Common stock [Member]
Related Party Transactions (Textual)
Payments of expenses on the Company's behalf
Related party [Member]
Related Party Transactions (Textual)
In kind contribution of interest					$ 1,100	$ 129
Proceeds from related party note				$ 7,694			$ 7,694
Related party [Member] | Notes Payable [Member]
Related Party Transactions (Textual)
Principal amount of unsecured promissory note			$ 100,000
Interest rate on unsecured promissory note, per annum			8.00%
Unsecured promissory note due date			Feb. 3, 2014
Repayment of loan balance to related party		$ 100,000
Accrued Interest		$ 5,333			$ 0	6,060
In kind contribution of interest						42
Related party expenses						$ 1,500	$ 2,023

Note Receivable (Details)

Note Receivable (Details) - USD ($)	Jul. 31, 2015	Jul. 31, 2014	Nov. 13, 2013
Note Receivable (Textual)
Allowance for doubtful accounts	$ 25,000	$ 25,000
Notes receivable advances to unrelated party			$ 25,000

Going Concern (Details)

Going Concern (Details) - USD ($)	12 Months Ended
	Jul. 31, 2015	Jul. 31, 2014
Going Concern (Textual)
Net cash used in operating activities	$ (400,988)	$ (161,283)
Net Loss	(118,802,407)	$ (189,399)
Working capital and stockholders' deficiency	$ 316,336

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	12 Months Ended
	Jul. 31, 2015	Jul. 31, 2014
Subsequent Events (Textual)
Common stock shares issued	100,000	328,978
Common stock shares issued, Value	$ 260,000	$ 273,056
Share price per share	$ 2.60
Dr. Guirguis [Member]
Subsequent Events (Textual)
Common stock shares issued	37,500,000
Common stock shares issued, Value	$ 118,125,000
Share price per share	$ 3.15
Subsequent Event [Member]
Subsequent Events (Textual)
Common stock shares issued	1,296,850
Share price per share	$ 0.33
Subsequent Event [Member] | Dr. Guirguis [Member]
Subsequent Events (Textual)
Common stock shares issued	675,638
Share price per share	$ 0.83
Common stock shares issued Value, Other	$ 205,000
Common stock shares issued Shares, Other	621,212
Bonus price per share	$ 0.33